(Q35638572)

9 August 2017

title

An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis (English)

1 reference

Irene van der Horst-Bruinsma

9 August 2017

0 references

0 references

13

object named as

van der Horst-Bruinsma I

1 reference

9 August 2017

Pham T

1

1 reference

9 August 2017

Landewé R

2

1 reference

9 August 2017

van der Linden S

3

1 reference

9 August 2017

Dougados M

4

1 reference

9 August 2017

Sieper J

5

1 reference

9 August 2017

Braun J

6

1 reference

9 August 2017

Davis J

7

1 reference

9 August 2017

Rudwaleit M

8

1 reference

9 August 2017

Collantes E

9

1 reference

9 August 2017

Burgos-Vargas R

10

1 reference

9 August 2017

Edmonds J

11

1 reference

9 August 2017

Olivieri I

12

1 reference

9 August 2017

Mielants H

14

1 reference

9 August 2017

Stone M

15

1 reference

9 August 2017

van der Heijde D

17

1 reference

9 August 2017

language of work or name

English

0 references

publication date

7 February 2006

1 reference

Annals of the Rheumatic Diseases

9 August 2017

published in

1 reference

9 August 2017

volume

65

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

1620-1625

1 reference

Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

Physiotherapy in ankylosing spondylitis: what is the evidence?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

Conventional treatments for ankylosing spondylitis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

Prognosis, course of disease, and treatment of the spondyloarthropathies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

Results from an open-label extension study of etanercept in ankylosing spondylitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798475

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16464984

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Infliximab treatment of severe ankylosing spondylitis: one-year followup

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16464984

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16464984

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ARD.2005.042630

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference

9 August 2017

1 reference